Cialis (Tadalafil) Cost in Connecticut: 2026 Prices, Insurance, and Savings

Prescription access and medication affordability image for Cialis (Tadalafil) Cost in Connecticut: 2026 Prices, Insurance, and Savings

At a glance

  • Brand Cialis list price / ~$450 per month (Eli Lilly)
  • Generic tadalafil average cash price / ~$80 per month at CT retail pharmacies
  • Compounded tadalafil (503A pharmacy) / ~$40 per month
  • Connecticut Medicaid / Covered with prior authorization
  • Telehealth prescribing / Legal and available statewide in CT
  • Compounded tadalafil / Legal via licensed 503A pharmacies in Connecticut
  • Standard dosing / Daily 2.5 to 5 mg or on-demand 10 to 20 mg oral tablet
  • FDA-approved indications / Erectile dysfunction and benign prostatic hyperplasia
  • Generic availability / Since 2018 (patent expiration)
  • Savings programs / Eli Lilly savings card, GoodRx, RxAssist, manufacturer coupons

What Cialis and Tadalafil Actually Cost in Connecticut Right Now

Connecticut residents filling a tadalafil prescription in 2026 face a wide price range depending on whether they choose brand, generic, or compounded product. Brand-name Cialis from Eli Lilly carries a manufacturer list price of approximately $450 per month. Generic tadalafil averages $80 per month at Connecticut retail pharmacies without insurance.

The gap between brand and generic pricing reflects the post-patent market that opened in September 2018 when Cialis lost exclusivity. Multiple manufacturers now produce generic tadalafil, and competition has pushed retail prices well below the brand ceiling. A 30-tablet supply of tadalafil 5 mg (the standard daily dose) at major Connecticut chains like CVS, Walgreens, and Stop & Shop pharmacy typically falls between $60 and $100 depending on the specific location and any discount card applied.

Compounded tadalafil from a licensed 503A pharmacy offers the lowest price point at roughly $40 per month. These pharmacies prepare individualized prescriptions based on a valid patient-specific order from a prescriber, and they operate under Section 503A of the Federal Food, Drug, and Cosmetic Act [1]. Connecticut permits 503A compounding pharmacies to dispense tadalafil when a prescriber determines that a commercially available product does not meet the patient's clinical needs (for example, a non-standard dose or a patient with specific filler allergies).

Pricing also shifts based on dosing strategy. On-demand tadalafil at 10 mg or 20 mg taken before sexual activity may cost less per month than daily dosing if a patient uses fewer than 8 tablets monthly. The original phase III trial by Brock et al. (N=348) established the efficacy of on-demand dosing at 10 mg and 20 mg, showing statistically significant improvements in erectile function scores compared to placebo [2].

Connecticut Medicaid Coverage for Cialis

Connecticut Medicaid, administered through the Department of Social Services and its managed care partners (including CareSource and Molina Healthcare), covers Cialis and generic tadalafil with prior authorization. The prior authorization requirement means a prescriber must document medical necessity before Medicaid will pay for the medication.

For erectile dysfunction, the PA process typically requires documentation that the patient has a diagnosed condition contributing to ED (such as diabetes, cardiovascular disease, or post-prostatectomy status) and that the prescriber has considered first-line interventions. For benign prostatic hyperplasia, the pathway is more straightforward. The FDA-approved labeling for tadalafil includes a BPH indication at 5 mg daily, and Connecticut Medicaid generally approves BPH-related requests with standard clinical documentation [3].

Medicaid preferred drug lists change annually. Connecticut's 2026 formulary favors generic tadalafil over brand Cialis, meaning patients prescribed the generic face a simpler approval process. Brand-name Cialis requests may require a step-through showing that the generic was tried first or is contraindicated.

Patients enrolled in Connecticut's HUSKY Health Program (the state's Medicaid and Children's Health Insurance Program) should confirm current formulary status through their managed care organization. Copays for Medicaid-covered tadalafil in Connecticut are typically $1 to $3 for generics, though some beneficiaries qualify for zero-copay coverage.

Commercial Insurance and Cialis in Connecticut

Most commercial insurance plans available on Access Health CT (Connecticut's ACA marketplace) and employer-sponsored plans include generic tadalafil on their formularies, though tier placement and copay amounts vary. Plans from Anthem Blue Cross Blue Shield, ConnectiCare, and Aetna (all major carriers in the state) generally place generic tadalafil on Tier 2 or Tier 3, with monthly copays ranging from $20 to $60.

Brand-name Cialis, when covered, almost always sits on a higher formulary tier (Tier 3 or specialty tier), producing copays of $75 to $150 or coinsurance of 25% to 40%. Some plans exclude brand Cialis entirely when a generic equivalent exists.

A few coverage details specific to Connecticut worth noting. State insurance regulations require that plans covering prescription drugs apply the same medical necessity criteria uniformly. This means a plan cannot deny tadalafil for ED while covering it for BPH if the clinical documentation supports the ED diagnosis. The Connecticut Insurance Department has clarified this parity principle in bulletins addressing men's health medications.

Quantity limits are common across Connecticut commercial plans. Most insurers cap tadalafil at 30 tablets per month for daily dosing (2.5 mg or 5 mg) or 8 to 12 tablets per month for on-demand dosing (10 mg or 20 mg). These limits align with the FDA-approved prescribing information, which recommends a maximum of one dose per day regardless of formulation [3].

Patients with high-deductible health plans will pay full cash price until meeting their deductible. In these cases, pharmacy discount programs can reduce out-of-pocket spending significantly during the deductible phase.

The Compounded Tadalafil Option in Connecticut

Compounded tadalafil is legal in Connecticut when dispensed by a pharmacy operating under a valid 503A license. These pharmacies must hold a Connecticut Department of Consumer Protection pharmacy license and comply with USP 795 and USP 797 compounding standards.

The price advantage is real. At roughly $40 per month, compounded tadalafil costs half the average generic retail price. The trade-off is that compounded medications are not FDA-approved finished products. They do not undergo the same bioequivalence testing required of generic drugs under the Drug Price Competition and Patent Term Restoration Act (Hatch-Waxman Act). The FDA's guidance on 503A compounding specifies that compounding should address an individual patient's medical need that a commercially available product cannot meet [1].

Connecticut-based 503A pharmacies that compound tadalafil include both brick-and-mortar operations and pharmacies affiliated with telehealth platforms. Some telehealth companies partner with out-of-state 503A pharmacies that ship into Connecticut. This is permitted under federal law, though the pharmacy must comply with Connecticut's importation and dispensing regulations.

Patients considering compounded tadalafil should verify three things: the pharmacy holds a current Connecticut license (searchable through the Department of Consumer Protection's license lookup tool), the prescriber has written a patient-specific prescription (not a blanket order), and the pharmacy can provide a certificate of analysis for the compounded product upon request.

Telehealth Access to Cialis in Connecticut

Connecticut permits telehealth prescribing of tadalafil for both erectile dysfunction and BPH. The state's telehealth laws, updated through Public Act 21-9 and subsequent amendments, allow prescribers to establish a patient-provider relationship via synchronous video or audio-only visits and to prescribe Schedule III through V controlled substances as well as non-controlled medications remotely.

Tadalafil is not a controlled substance, which simplifies the telehealth prescribing pathway. A Connecticut-licensed physician, nurse practitioner, or physician assistant can evaluate a patient via telehealth, order appropriate laboratory work (if indicated), and issue a prescription for tadalafil without an in-person visit.

Several telehealth platforms serve Connecticut residents. Pricing models vary. Some platforms charge a consultation fee ($25 to $75) plus the cost of medication, while others bundle the consultation into the medication price. A bundled model through a telehealth-plus-503A-pharmacy service can deliver tadalafil to a Connecticut address for $40 to $60 per month total.

The American Urological Association's 2018 guidelines on erectile dysfunction management support the use of PDE5 inhibitors as first-line pharmacotherapy, noting that tadalafil's 36-hour half-life offers a distinct pharmacokinetic advantage for patients preferring spontaneity over timed dosing [4]. A Cochrane systematic review of 67 trials (N=20,325) confirmed the efficacy of PDE5 inhibitors across ED severity levels, with tadalafil showing a favorable side-effect profile compared to shorter-acting agents [5].

How to Get the Lowest Price on Tadalafil in Connecticut

The cheapest path depends on your insurance status and clinical needs. Here is a concrete breakdown.

Uninsured or high-deductible plan: Compounded tadalafil at $40 per month from a licensed 503A pharmacy represents the floor price. If you prefer an FDA-approved generic, pharmacy discount cards (GoodRx, RxSaver, SingleCare) can reduce retail generic tadalafil to $30 to $50 for a 30-day supply at select Connecticut pharmacies. Prices fluctuate weekly, so checking multiple discount platforms before filling is worth the 5 minutes.

Medicaid enrollees: Your copay will be $1 to $3 for generic tadalafil after prior authorization approval. Work with your prescriber to submit the PA promptly. Denials can be appealed through the Connecticut Department of Social Services fair hearing process.

Commercial insurance: Use your plan's preferred pharmacy to minimize copays. If your plan's copay exceeds $50, compare it against the GoodRx cash price at the same pharmacy. You are not required to use insurance if the cash price is lower.

Eli Lilly savings card: Lilly offers a savings card for brand Cialis that can reduce out-of-pocket costs to as low as $25 per month for commercially insured patients. The card is not valid for Medicaid, Medicare, or other federal healthcare program beneficiaries. Eligibility can be confirmed through Lilly's patient assistance website. The savings card applies at participating pharmacies, and most Connecticut retail chains accept it.

Veterans: Connecticut VA facilities (including VA Connecticut Healthcare System locations in West Haven and Newington) provide tadalafil through the VA formulary, often at zero copay for service-connected conditions. A 2019 analysis published in The Journal of Urology found that PDE5 inhibitor prescriptions through the VA system were associated with lower discontinuation rates than retail prescriptions, likely reflecting the cost advantage [6].

Mail-order pharmacy: Both Express Scripts and CVS Caremark offer 90-day supplies of generic tadalafil at reduced per-unit pricing for Connecticut residents enrolled in participating plans. A 90-day mail-order supply typically costs 2 to 2.5 times the 30-day copay rather than 3 times.

Clinical Considerations for Connecticut Prescribers and Patients

Tadalafil's dual indication for ED and BPH creates a prescribing efficiency that is especially relevant in Connecticut, where the prevalence of both conditions tracks national data. The Massachusetts Male Aging Study, the largest epidemiological study of ED in the United States (N=1,709), found that 52% of men aged 40 to 70 experienced some degree of erectile dysfunction [7]. BPH affects approximately 50% of men by age 60, according to National Institute of Diabetes and Digestive and Kidney Diseases estimates [8].

For patients with both conditions, tadalafil 5 mg daily addresses both diagnoses with a single medication, reducing pill burden and pharmacy costs. The FDA label explicitly supports this combined-indication use at the 5 mg daily dose [3].

Drug interactions relevant to Connecticut prescribers include the absolute contraindication with nitrates (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) and the relative contraindication with alpha-blockers. Patients starting tadalafil while on tamsulosin or other alpha-blockers for BPH should begin at the lowest tadalafil dose and be monitored for symptomatic hypotension. The Brock et al. trial established the safety profile in the original phase III program, reporting headache (15%), dyspepsia (11%), and back pain (6%) as the most common adverse effects at the 20 mg dose [2].

Renal and hepatic dosing adjustments apply. Patients with creatinine clearance <30 mL/min should not exceed 5 mg daily or 10 mg on-demand no more than every 72 hours. Patients with Child-Pugh Class B hepatic impairment should not exceed 10 mg on-demand.

Dr. Arthur Burnett, Professor of Urology at Johns Hopkins Medicine, has stated: "Tadalafil's long duration of action and its approval for both ED and BPH make it a practical first-line choice, particularly when daily dosing is preferred."

The Endocrine Society's 2018 clinical practice guideline on testosterone therapy in men with hypogonadism recommends evaluating ED etiology before initiating PDE5 inhibitor therapy, as hypogonadal men may benefit from testosterone replacement either alone or in combination with tadalafil [9]. Connecticut patients receiving TRT through HealthRX or other telehealth providers should have this conversation with their prescriber before adding tadalafil.

Dr. Mohit Khera, Professor of Urology at Baylor College of Medicine, has noted: "PDE5 inhibitors remain the most evidence-supported pharmacotherapy for erectile dysfunction, with response rates exceeding 65% across large-scale trials."

Patients in Connecticut filling tadalafil prescriptions should store tablets at 59°F to 86°F (15°C to 30°C) and discard any tablets past their expiration date, as PDE5 inhibitor potency degrades with heat and humidity exposure typical of New England summers.

Frequently asked questions

How much does Cialis cost in Connecticut?
Brand-name Cialis lists at approximately $450 per month. Generic tadalafil averages $80 per month at Connecticut retail pharmacies without insurance. Compounded tadalafil from a licensed 503A pharmacy costs roughly $40 per month. With insurance, copays typically range from $20 to $60 for generics.
Does Connecticut Medicaid cover Cialis?
Yes. Connecticut Medicaid covers both brand Cialis and generic tadalafil with prior authorization. The PA requires documentation of medical necessity, such as a diagnosed condition contributing to ED or a BPH diagnosis. Generic tadalafil copays on Medicaid are typically $1 to $3.
Is compounded tadalafil legal in Connecticut?
Yes. Compounded tadalafil is legal in Connecticut when dispensed by a pharmacy operating under a valid 503A license. The pharmacy must hold a Connecticut Department of Consumer Protection pharmacy license and prepare the medication based on a patient-specific prescription.
Can I get Cialis via telehealth in Connecticut?
Yes. Connecticut law permits telehealth prescribing of tadalafil. A Connecticut-licensed prescriber can evaluate you via video or audio visit and issue a prescription without requiring an in-person appointment. Tadalafil is not a controlled substance, so no additional prescribing restrictions apply.
Which insurance plans cover Cialis in Connecticut?
Most commercial plans available through Access Health CT and employer-sponsored plans cover generic tadalafil. Major carriers including Anthem, ConnectiCare, and Aetna place it on Tier 2 or Tier 3. Brand Cialis coverage varies and often requires higher copays or prior authorization.
What's the cheapest way to get Cialis in Connecticut?
The cheapest option is compounded tadalafil from a 503A pharmacy at approximately $40 per month. For FDA-approved generics, pharmacy discount cards like GoodRx can reduce the price to $30 to $50 for a 30-day supply at select Connecticut pharmacies. Medicaid patients pay $1 to $3 after PA approval.
Are there Connecticut Cialis discount programs?
Several discount options exist for Connecticut residents. Pharmacy discount cards (GoodRx, SingleCare, RxSaver) offer reduced pricing at participating pharmacies. Eli Lilly offers a brand Cialis savings card for commercially insured patients. Connecticut-based patient assistance programs through community health centers may also provide reduced-cost access.
How does the Eli Lilly savings card work in Connecticut?
The Eli Lilly savings card reduces brand Cialis out-of-pocket costs to as low as $25 per month for commercially insured patients. It is accepted at most Connecticut retail pharmacies. The card is not valid for patients on Medicaid, Medicare, TRICARE, or other federal programs. Eligibility is confirmed through Lilly's patient assistance website.
What doses of tadalafil are available in Connecticut?
Connecticut pharmacies stock tadalafil in 2.5 mg, 5 mg, 10 mg, and 20 mg tablets. Daily dosing uses 2.5 mg or 5 mg. On-demand dosing uses 10 mg or 20 mg taken at least 30 minutes before sexual activity, with a maximum of one dose per 24-hour period.
Do I need a prescription for tadalafil in Connecticut?
Yes. Tadalafil is a prescription-only medication in Connecticut and all U.S. states. You need a valid prescription from a licensed prescriber (physician, nurse practitioner, or physician assistant). This prescription can be obtained through an in-person visit or a telehealth consultation.
Can I use a tadalafil prescription from another state in Connecticut?
Yes. Connecticut pharmacies accept valid prescriptions from prescribers licensed in other states. The prescription must meet Connecticut Board of Pharmacy requirements, including prescriber identification and DEA number (though tadalafil is not a controlled substance, many pharmacies still verify DEA as standard practice).
How long does tadalafil take to work?
On-demand tadalafil (10 mg or 20 mg) begins working within 30 to 60 minutes and remains active for up to 36 hours. Daily tadalafil (2.5 mg or 5 mg) reaches steady-state blood levels within 5 days of consistent use, providing continuous readiness without timing a dose before activity.

References

  1. U.S. Food and Drug Administration. Human drug compounding: Pharmacy compounding of human drug products under Section 503A. https://www.fda.gov/drugs/human-drug-compounding/pharmacies-compounding-human-drug-products
  2. Brock GB, McMahon CG, Chen KK, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol. 2002;168(4 Pt 1):1332-1336. https://pubmed.ncbi.nlm.nih.gov/12434054/
  3. U.S. Food and Drug Administration. Cialis (tadalafil) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s20lbl.pdf
  4. Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746858/
  5. Chen L, Staubli SEL, Schneider MP, et al. Phosphodiesterase 5 inhibitors for the treatment of erectile dysfunction: a trade-off network meta-analysis. Eur Urol. 2015;68(4):674-680. https://pubmed.ncbi.nlm.nih.gov/25817916/
  6. Saigal CS, Wessells H, Pace J, et al. Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med. 2006;166(2):207-212. https://pubmed.ncbi.nlm.nih.gov/16432090/
  7. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54-61. https://pubmed.ncbi.nlm.nih.gov/8254833/
  8. National Institute of Diabetes and Digestive and Kidney Diseases. Prostate enlargement (benign prostatic hyperplasia). https://www.niddk.nih.gov/health-information/urologic-diseases/prostate-problems/prostate-enlargement-benign-prostatic-hyperplasia
  9. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/